Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to 0.24%.

  • Roivant Sciences' Return on Capital Employed fell 9900.0% to 0.24% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.24%, marking a year-over-year decrease of 9900.0%. This contributed to the annual value of 0.18% for FY2025, which is 8300.0% down from last year.
  • Latest data reveals that Roivant Sciences reported Return on Capital Employed of 0.24% as of Q4 2025, which was down 9900.0% from 0.25% recorded in Q3 2025.
  • In the past 5 years, Roivant Sciences' Return on Capital Employed registered a high of 0.96% during Q4 2023, and its lowest value of 0.69% during Q3 2022.
  • For the 5-year period, Roivant Sciences' Return on Capital Employed averaged around 0.13%, with its median value being 0.3% (2021).
  • As far as peak fluctuations go, Roivant Sciences' Return on Capital Employed surged by 15600bps in 2023, and later crashed by -10200bps in 2025.
  • Quarter analysis of 5 years shows Roivant Sciences' Return on Capital Employed stood at 0.48% in 2021, then dropped by -25bps to 0.6% in 2022, then soared by 259bps to 0.96% in 2023, then decreased by -21bps to 0.75% in 2024, then tumbled by -132bps to 0.24% in 2025.
  • Its last three reported values are 0.24% in Q4 2025, 0.25% for Q3 2025, and 0.2% during Q2 2025.